Analytical Inclusivity of Three Commercial Real-Time PCR Platforms Against Carbapenemase Allelic Variants in Peruvian Clinical Isolates
Year: 2026
Type: article
Abstract: Objectives: Rapid molecular detection of carbapenemase-producing Gram-negative bacilli is crucial for targeted antimicrobial therapy, but regional gene sequence diversity can impair commercial PCR assays. This study evaluated the analytical inclusivity of three commercial real-time PCR platforms (Xpert Carba-R on the GeneXpert system, Galaxy Lite, and Molecular Mouse) against carbapenemase alleles circulating in Peru, including the regionally relevant blaIMP-74 and blaIMP-93 alleles. Methods: We analyzed a positive-enriched challenge panel of 23 non-duplicate clinical isolates previously characterized by whole-genome sequencing (WGS): 10 Enterobacterales and 13 Pseudomonas aeruginosa carrying 26 carbapenemase genes across 12 variants (blaKPC-2/35, blaNDM-1/5, blaOXA-48/181/232, blaVIM-2, and blaIMP-16/18/74/93); inclusivity was calculated per WGS-confirmed target gene, and Molecular Mouse was evaluated on a 16-target subset including at least one representative of each allele. Results: Galaxy Lite detected all carbapenemase alleles evaluated (12/12 alleles; gene-level analytical inclusivity 100%, 26/26 target genes, 95% CI: 86.8–100%). Xpert Carba-R and Molecular Mouse each detected 8 of the 12 alleles (100% of KPC, NDM, OXA-48-like, and VIM alleles), failing to detect any of the four IMP alleles evaluated. Overall gene-level inclusivity was 53.8% (14/26 target genes, 95% CI: 33.4–73.4%) for Xpert Carba-R and 62.5% (10/16 target genes, 95% CI: 35.4–84.8%) for Molecular Mouse. Conclusions: In this small, positive-enriched panel, two of the three commercial PCR panels did not detect the IMP alleles tested, a finding that may be related to primer/probe–target sequence divergence, although this mechanism was not investigated. These results support the local verification of commercial carbapenemase PCR assays against circulating alleles before routine implementation.
Source: Diagnostics
Institution: Universidad Ricardo Palma
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236831020
